Paul Bello

Wellcome/MRC Cambridge Stem Cell Institute

Papers

1

Total Citations

47

H-Index

1

About

Paul Bello is a researcher whose work sits at the intersection of stem cell biology, automated cell culture technologies, and chemical screening methodologies. His most recognized contribution centers on the development of scalable platforms for studying human induced pluripotent stem cell–derived neuroepithelial-like stem cells (NESCs), a cell type of considerable interest for modeling neurological disease and advancing regenerative medicine. In his highly cited 2012 study, Bello and colleagues pioneered an automated, large-scale culture system paired with a medium-throughput chemical screen designed to identify modulators of proliferation and cellular viability in these neural stem cell populations. With 47 citations, this work has proven meaningful to researchers seeking reproducible, high-content approaches to stem cell manipulation and drug discovery. By bridging automation engineering with neural stem cell biology, Bello's research addresses a critical bottleneck in translational neuroscience — namely, the challenge of producing and screening neural cells at the scale required for meaningful therapeutic insight. His contributions offer valuable tools for scientists working on neurodevelopmental disorders, drug toxicity testing, and the identification of compounds with neuroregenerative potential.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Automated Large-Scale Culture and Medium-Throughput Chemical Screen for Modulators of Proliferation and Viability of Human Induced Pluripotent Stem Cell–Derived Neuroepithelial-like Stem Cells
47 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Wellcome/MRC Cambridge Stem Cell Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago